Brigido Stephen 4

4 · Celularity Inc · Filed Apr 15, 2026

AI-generated summary of this filing

Updated Apr 15, 2026

Celularity (CELU) Pres. Stephen Brigido Receives 821 Shares via RSU Vest

What Happened

Stephen Brigido, President, Functional Regeneration at Celularity Inc., had 821 restricted stock units (RSUs) vest and convert into Class A common stock on April 13, 2026. The conversion is reported as an exercise/conversion of a derivative (code M) at $0.00.
To cover tax withholding, 268 of those shares were surrendered (disposed) at $1.28 per share for a withholding value of $343.04 (code F). Net shares retained from this vesting event are 553 shares (821 vested − 268 withheld).
This was an award/vesting event (routine executive compensation), not an open‑market purchase or sale.

Key Details

Transaction date: April 13, 2026; Form filed April 15, 2026 (period of report Apr 13, 2026).
Reported entries: conversion of 821 RSUs to shares (acquired at $0.00); 268 shares withheld for taxes at $1.28/share (≈ $343).
Source of RSUs: Grant of 3,281 RSUs on April 13, 2022; 25% (821 RSUs) vested on April 13, 2026 (see footnotes F1–F4).
Shares owned after the transaction are not disclosed in the excerpt of the filing.
Filing does not indicate a late report; this is a standard RSU vest + share‑withholding for taxes.

Context and plain‑language note:

RSUs are a form of equity compensation that convert to actual shares when they vest. The share withholding is a common way to satisfy tax obligations and does not represent a market sale by the insider for investment reasons.

Form 4

Period: 2026-04-13

Pres., Functional Regeneration

Transactions

Exercise/Conversion
Class A Common Stock
[F1]
2026-04-13+821→ 9,742 total
Tax Payment
Class A Common Stock
[F2]
2026-04-13$1.28/sh−268$343→ 9,474 total
Exercise/Conversion
Restricted Stock Units
[F3][F4]
2026-04-13−821→ 0 total
→ Class A Common Stock (821 underlying)

Footnotes (4)

[F1]Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022.
[F2]This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2026.
[F3]Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock.
[F4]On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2026. The Class A Common Stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4.

Signature

/s/ Stephen Brigido|2026-04-15

1 file